A case of ABO-incompatible blood transfusion treated by plasma exchange therapy and continuous hemodiafiltration

CEN Case Rep. 2018 May;7(1):114-120. doi: 10.1007/s13730-018-0307-4. Epub 2018 Jan 31.

Abstract

ABO-incompatible blood transfusion is potentially a life-threatening event. A 74-year-old type O Rh-positive male was accidentally transfused with 280 mL type B Rh-positive red blood cells during open right hemicolectomy, causing ABO-incompatible blood transfusion. Immediately after the transfusion, the patient experienced a hypotension episode followed by acute hemolytic reaction, disseminated intravascular coagulation and acute kidney injury. Plasma exchange therapy was performed to remove anti-B antibody and free hemoglobin because they caused acute hemolytic reaction, disseminated intravascular coagulation, and acute kidney injury. Free hemoglobin levels decreased from 13 to 2 mg/dL for 2 h. Continuous hemodiafiltration was used to stabilize hemodynamics. The patient was successfully treated for acute hemolytic reaction, disseminated intravascular coagulation, and acute kidney injury. Plasma exchange therapy and continuous hemodiafiltration are likely to be effective treatments for ABO-incompatible blood transfusion, and further studies are required to assess this effectiveness in future.

Keywords: Acute hemolytic reaction; Acute kidney injury; Continuous hemodiafiltration; Disseminated intravascular coagulation; Incompatible blood transfusion; Plasma exchange therapy.